Clinical Trial Update: Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating the combination of cyclophosphamide and filgrastim in patients with stage IV, relapsed or refr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Neupogen (Filgrastim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED